痰热清注射液联合头孢替安治疗社区获得性肺炎的临床疗效观察  

Clinical Effect of Tanreqing Injection Combined with Cefotiam in the Treatment of Community Acquired Pneumonia

作　　者：钟华[1] 徐小红[1] 潘凤娟[1] 林俊仪 孙惠[1] 

机构地区：[1]广东省农垦中心医院,湛江524002

出　　处：《数理医药学杂志》2017年第11期1681-1683,共3页Journal of Mathematical Medicine

摘　　要：目的:观察社区获得性肺炎(Community Acquired Pneumonia,CAP)采用痰热清注射液联合头孢替安治疗的临床效果分析。方法:将在某院近期(2014年1月~2017年6月时期)收治住院、符合CAP诊断的75例患者,依照治疗方式分成两组。其中采用痰热清联合头孢替安治疗的35例患者称为实验组,采用溴已新联合头孢替安治疗的40例患者称为对照组,分析其治疗效果与不良反应。结果:疗程结束后实验组总有效率为97.14%,对照组为77.50%;实验组不良反应率为5.72%,对照组不良反应率为25%,差异具有统计学意义(P<0.05)。结论:对于社区获得性肺炎患者,采用痰热清注射液联合头孢替安治疗,可取得较好的临床治疗效果,且不良反应较少,值得临床推广。Objective:To investigate the clinical efficacy of Tanreqing injection combined with cefotiam in the treatment of community acquired pneumonia(Community Acquired Pneumonia,CAP).Methods:75 patients with CAP hospitalized in a hospital from January 2014 to June 2017 were divided into two groups ac-cording to treatment methods.Among them,35 patients treated with Tanreqing combined with ceftazidime were called the experimental group,and the other 40 patients treated with bromhexine combined cefotiam were named as the control group.The therapeutic effects and adverse reactions were analyzed.Results:After the course of treatment,the total effective rate was 97.14%in the experimental group and 77.50%in the control grou,and the incidence of adverse reaction was 5.72%in the experimental group and 25%in the control group,which the differences were statistically significant(P<0.05).Conclusion:For patients with community-acquired pneumonia,Tanreqing injection combined with cefotiam treatment has good curative effect,with less adverse reactions,which is worthy of clinical promotion.

关 键 词：社区获得肺炎 痰热清注射液 联合头孢替安 临床疗效 分析观察 

分 类 号：R563.19[医药卫生—呼吸系统]